.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

PRANDIMET Drug Profile

« Back to Dashboard
Prandimet is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier.

The generic ingredient in PRANDIMET is metformin hydrochloride; repaglinide. There are forty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; repaglinide profile page.

Summary for Tradename: PRANDIMET

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices: :see details

Pharmacology for Tradename: PRANDIMET

Ingredient-typeBiguanides
Drug ClassGlinide
Biguanide
Mechanism of ActionPotassium Channel Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-001Jun 23, 2008RXNo► subscribe► subscribe
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-002Jun 23, 2008RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PRANDIMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-001Jun 23, 2008RE37035► subscribe
Novo Nordisk Inc
PRANDIMET
metformin hydrochloride; repaglinide
TABLET;ORAL022386-002Jun 23, 2008RE37035► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PRANDIMET

Drugname Dosage Strength RLD Submissiondate
repaglinide and metformin hydrochlorideTablets1 mg/500 mg and 2 mg/500 mgPrandimet4/9/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

12
`abc